Reaction

Periarthritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,222 reports · 41 co-occurring drugs

As of the last recalculation, Periarthritis appears in 2,222 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is DEXTROSE (PRR 23.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dextrose	33	23.8	23.9
Dextrose Monohydrate	33	23.5	23.5
Captopril	20	19.7	19.7
Methylprednisolone Acetate	13	15.3	15.3
Felodipine Extended-Release Tablets	14	11.6	11.6
Felodipine	14	11.6	11.6
Alendronate Sodium	114	11.1	11.1
Standardized Senna Concentrate	13	9.7	9.7
Nebivolol	15	8.9	8.9
Liothyronine Sodium	8	8.6	8.6
Desoximetasone	17	8.4	8.4
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	8	7.5	7.5
Primidone	8	7.4	7.4
Tofacitinib Citrate	10	7.2	7.2
Vibegron	6	7.0	7.0
Dolutegravir Sodium	6	6.2	6.2
Lanreotide Acetate	5	6.0	6.0
Dorzolamide Hydrochloride And Timolol Maleate	5	5.9	5.9
Nebivolol Hydrochloride	20	5.6	5.6
Rucaparib	5	5.3	5.3
Brimonidine Tartrate	10	5.3	5.3
Insulin Degludec	13	5.2	5.2
Pioglitazone	22	4.8	4.8
Asfotase Alfa	5	4.7	4.7
Naltrexone Hydrochloride And Bupropion Hydrochloride	4	4.4	4.4
Omalizumab	38	4.2	4.2
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	3.6	3.6
Pseudoephedrine Hcl	4	3.4	3.4
Belimumab	11	3.3	3.3
Sodium Oxybate	22	3.1	3.1
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	3	3.1	3.1
Denosumab	62	2.9	2.9
Abemaciclib	6	2.8	2.8
Conjugated Estrogens And Medroxyprogesterone Acetate	7	2.8	2.8
Romosozumab-Aqqg	4	2.8	2.8
Olaparib	6	2.7	2.7
Diroximel Fumarate	3	2.4	2.4
Ixazomib	7	2.3	2.3
Onabotulinumtoxina	17	2.1	2.1
Dimethyl Fumarate	26	2.0	2.0
Galcanezumab-Gnlm	4	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.